A Phase 1b, Randomized, Blinded, Dose-Determined Study Evaluating the Safety and Tolerability of Intervention with AT-100 (rhSP-D) in Preterm Neonates at High Risk for the Development of Bronchopulmonary Dysplasia (BPD)